{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T01:19:58Z","timestamp":1775438398089,"version":"3.50.1"},"reference-count":8,"publisher":"The Endocrine Society","issue":"2","license":[{"start":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T00:00:00Z","timestamp":1742774400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,21]]},"DOI":"10.1210\/clinem\/dgaf165","type":"journal-article","created":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T02:57:51Z","timestamp":1742698671000},"page":"e636-e637","source":"Crossref","is-referenced-by-count":5,"title":["Elucidating the Impact of Elexacaftor\/Tezacaftor\/Ivacaftor on Glucose Intolerance in People With Cystic Fibrosis"],"prefix":"10.1210","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0622-5262","authenticated-orcid":false,"given":"Bibi Uhre","family":"Nielsen","sequence":"first","affiliation":[{"name":"Cystic Fibrosis Centre Copenhagen, Department of Infectious Diseases, Copenhagen University Hospital\u2014Rigshospitalet , 2100 Copenhagen ,","place":["Denmark"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2893-3211","authenticated-orcid":false,"given":"James A M","family":"Shaw","sequence":"additional","affiliation":[{"name":"Translational and Clinical Research Institute, Newcastle University , Newcastle upon Tyne NE1 7RU ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2025,3,24]]},"reference":[{"issue":"10","key":"2026012101515894200_dgaf165-B1","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1007\/s00125-024-06220-6","article-title":"Insulin sensitivity, disposition index and insulin clearance in cystic fibrosis: a cross-sectional study","volume":"67","author":"Nielsen","year":"2024","journal-title":"Diabetologia"},{"issue":"(9)","key":"2026012101515894200_dgaf165-B2","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1210\/clinem\/dgae857","article-title":"Glycemia and insulin secretion in cystic fibrosis 2 years after elexacaftor\/tezacaftor\/ivacaftor: PROMISE-ENDO","volume":"110","author":"Chan","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"2026012101515894200_dgaf165-B3","doi-asserted-by":"crossref","first-page":"852551","DOI":"10.3389\/fped.2022.852551","article-title":"Short-term effects of elexacaftor\/tezacaftor\/ivacaftor combination on glucose tolerance in young people with cystic fibrosis\u2014an observational pilot study","volume":"10","author":"Korten","year":"2022","journal-title":"Front Pediatr"},{"issue":"4","key":"2026012101515894200_dgaf165-B4","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.jcf.2023.01.004","article-title":"Improved glucose tolerance after initiation of elexacaftor\/tezacaftor\/ivacaftor in adults with cystic fibrosis","volume":"22","author":"Steinack","year":"2023","journal-title":"J Cyst Fibros"},{"issue":"1","key":"2026012101515894200_dgaf165-B5","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1210\/clinem\/dgad443","article-title":"Preservation of \u03b2-cell function in pancreatic insufficient cystic fibrosis with highly effective CFTR modulator therapy","volume":"109","author":"Flatt","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"2026012101515894200_dgaf165-B6","first-page":"100311","article-title":"Glycemia and \u03b2-cell function before and after elexacaftor\/tezacaftor\/ivacaftor in youth and adults with cystic fibrosis","volume":"30","author":"Chan","year":"2022","journal-title":"J Clin Transl Endocrinol"},{"issue":"1):","key":"2026012101515894200_dgaf165-B7","first-page":"103","article-title":"Decline in HbA1c during the first year of elexacaftor\/tezacaftor\/ivacaftor treatment in the Danish cystic fibrosis cohort: short title: decline in HbA1c after elexacaftor\/tezacaftor\/ivacaftor treatment","volume":"23","author":"Nielsen","year":"2023","journal-title":"J Cyst Fibros"},{"issue":"5","key":"2026012101515894200_dgaf165-B8","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1210\/clinem\/dgz209","article-title":"In situ analysis reveals that CFTR is expressed in only a small minority of \u03b2-cells in normal adult human pancreas","volume":"105","author":"White","year":"2019","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgaf165\/62571990\/dgaf165.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/2\/e636\/62571990\/dgaf165.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/2\/e636\/62571990\/dgaf165.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T06:52:05Z","timestamp":1768978325000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/111\/2\/e636\/8092258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,24]]},"references-count":8,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,3,24]]},"published-print":{"date-parts":[[2026,1,21]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgaf165","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2]]},"published":{"date-parts":[[2025,3,24]]}}}